首页> 外文期刊>Cardiology and therapy. >Perceived Benefits of Implantable Cardioverter Defibrillator Implantation among Heart Failure Patients and Its Relation to Quality of Life: A Cross-Sectional Study
【24h】

Perceived Benefits of Implantable Cardioverter Defibrillator Implantation among Heart Failure Patients and Its Relation to Quality of Life: A Cross-Sectional Study

机译:心力衰竭患者植入式心脏复律除颤器的感知益处及其与生活质量的关系:一项跨领域研究

获取原文
       

摘要

Introduction Patients with heart failure (HF) and implantable cardioverter defibrillators (ICDs) may misunderstand the indication of ICDs due to unsatisfactory information. The goal of this study is to evaluate the patient perspective of ICD indication and its relation to quality of life, as well as to identify probable communication gaps between doctors and ICD receivers. Methods A total of 119 patients with HF who were implanted with a single-chamber ICD were evaluated in outpatient clinics. Patients with cardiac resynchronization therapy-defibrillators were not included in the study. In a questionnaire, patients were asked about the indication of the ICD procedure and classified according to the perceived benefits. Results This study showed that most of the patients ( n =?92, 77.3%) believed that ICD was implanted for improvement of heart dysfunction or for symptom relief. According to the perceived benefit groups, physical function, general health, vitality, and role physical scores were significantly lower in the symptom relief group ( p Conclusion Patients with HF and ICD mostly believed that the cardioverter defibrillator implanted for improving heart function or symptom relief. Doctors play a significant role when a patient is first referred for ICD because less-informed patients are more prone to misunderstand the procedure’s benefits. Moreover, unfulfilled expectations may lead to loss of confidence in applied therapies and result in poor health outcomes.
机译:简介心力衰竭(HF)和植入式心脏复律除颤器(ICD)的患者可能会由于信息不满意而误解了ICD的指征。这项研究的目的是评估患者对ICD适应症的看法及其与生活质量的关系,并确定医生与ICD接收者之间可能存在的沟通差距。方法对119例单腔ICD的HF患者进行门诊评估。心脏再同步治疗用除颤器的患者未纳入研究。在问卷中,询问患者有关ICD程序的适应症,并根据感觉到的益处进行分类。结果该研究表明,大多数患者(n =?92,77.3%)认为植入ICD可以改善心脏功能障碍或缓解症状。根据感觉到的受益人群,在症状缓解组中,身体机能,总体健康,活力和角色身体得分均明显较低(p结论HF和ICD患者大多认为植入心脏复律除颤器可改善心脏功能或症状缓解。当患者初次接受ICD手术时,医生扮演着重要角色,因为消息灵通的患者更容易误诊该手术的益处,此外,期望值过高可能会导致对应用疗法的信心丧失,并导致健康状况不佳。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号